Insulin glargine and lixisenatide Subcutaneous and Tolterodine Extended-Release Capsules
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Tolterodine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: tolterodine
Brand name: Detrol, Detrol LA
Synonyms: Tolterodine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Tolterodine Tablets
- Insulin glargine and lixisenatide Subcutaneous-Tolterodine Tartrate
- Insulin glargine and lixisenatide Subcutaneous-Tolterodine Tartrate Capsules
- Insulin glargine and lixisenatide Subcutaneous-Tolterodine Tartrate Tablets
- Insulin glargine and lixisenatide Subcutaneous-Tolvaptan
- Insulin glargine and lixisenatide Subcutaneous-Tolvaptan (Jynarque/Jinarc)
- Tolterodine Extended-Release Capsules-Insulin glargine, recombinant Subcutaneous
- Tolterodine Extended-Release Capsules-Insulin glulisine
- Tolterodine Extended-Release Capsules-Insulin Glulisine (Cartridges and Pens)
- Tolterodine Extended-Release Capsules-Insulin Glulisine (Vials)
- Tolterodine Extended-Release Capsules-Insulin glulisine Subcutaneous
- Tolterodine Extended-Release Capsules-Insulin human inhaled Inhalation